blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4512477

EP4512477 - IMPROVED LAMP CONSTRUCTS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  31.10.2025
Database last updated on 28.03.2026
FormerThe application has been published
Status updated on  24.01.2025
Most recent event   Tooltip31.10.2025The date on which the examining division becomes responsible, has been established 
31.10.2025Request for examination filedpublished on 03.12.2025  [2025/49]
Applicant(s)For all designated states
Immunomic Therapeutics, Inc.
15010 Broschart Road Suite 250
Rockville, MD 20850 / US
[2025/09]
Inventor(s)01 / HEILAND, Teri
New Market, Maryland, 21774 / US
 [2025/09]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2025/09]
Application number, filing date24201125.222.04.2018
[2025/09]
Priority number, dateUS201762488741P22.04.2017         Original published format: US 201762488741 P
US201762549119P23.08.2017         Original published format: US 201762549119 P
US201762549033P23.08.2017         Original published format: US 201762549033 P
[2025/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4512477
Date:26.02.2025
Language:EN
[2025/09]
Type: A3 Search report 
No.:EP4512477
Date:11.06.2025
Language:EN
[2025/24]
Search report(s)(Supplementary) European search report - dispatched on:EP14.05.2025
ClassificationIPC:C07K14/705, A61K38/17, A61K39/00, C07K19/00
[2025/24]
CPC:
C07K14/70596 (EP,IL,KR,US); A61K38/00 (EP,IL,KR); A61K39/00115 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR,US); C07K14/705 (EP,IL); A61K2039/55522 (EP,IL,KR,US);
A61K2039/57 (EP,IL,US); A61K2039/575 (EP,IL,KR,US); A61K2039/6031 (EP,IL,KR,US);
A61K2039/70 (EP,IL,KR); C07K2319/02 (EP,IL,KR,US); C07K2319/03 (EP,IL,KR,US);
C07K2319/06 (EP); C07K2319/40 (EP,IL,KR,US); Y02A50/30 (EP,IL,KR) (-)
Former IPC [2025/09]A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2025/09]
TitleGerman:VERBESSERTE LAMPENKONSTRUKTIONEN[2025/09]
English:IMPROVED LAMP CONSTRUCTS[2025/09]
French:CONSTRUCTIONS DE LAMPE AMÉLIORÉES[2025/09]
Examination procedure27.10.2025Examination requested  [2025/49]
27.10.2025Date on which the examining division has become responsible
Parent application(s)   TooltipEP18726576.4  / EP3612556
Fees paidRenewal fee
17.10.2024Renewal fee patent year 03
17.10.2024Renewal fee patent year 04
17.10.2024Renewal fee patent year 05
17.10.2024Renewal fee patent year 06
17.10.2024Renewal fee patent year 07
28.07.2025Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.04.202508   M06   Fee paid on   05.08.2025
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A] WO2011046996  (UNIV JOHNS HOPKINS et al.)
 [A] WO2015200357  (IMMUNOMIC THERAPEUTICS INC et al.)
 [A] US2007269457  (NIAZI KAYVAN R et al.)
 [A]   L. B. ARRUDA ET AL: "Dendritic Cell-Lysosomal-Associated Membrane Protein (LAMP) and LAMP-1-HIV-1 Gag Chimeras Have Distinct Cellular Trafficking Pathways and Prime T and B Cell Responses to a Diverse Repertoire of Epitopes", THE JOURNAL OF IMMUNOLOGY, vol. 177, no. 4, 3 August 2006 (2006-08-03), US, pages 2265 - 2275, XP055266226, ISSN: 0022-1767, DOI: 10.4049/jimmunol.177.4.2265

DOI:   http://dx.doi.org/10.4049/jimmunol.177.4.2265
 [DA]   RODRIGO MACIEL DA COSTA GODINHO ET AL: "Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response", PLOS ONE, vol. 9, no. 6, 16 June 2014 (2014-06-16), pages e99887, XP055484045, DOI: 10.1371/journal.pone.0099887

DOI:   http://dx.doi.org/10.1371/journal.pone.0099887
 [A]   DELU ZHOU ET AL: "Lamp-2a Facilitates MHC Class II Presentation of Cytoplasmic Antigens", IMMUNITY., vol. 22, no. 5, 1 May 2005 (2005-05-01), US, pages 571 - 581, XP055483518, ISSN: 1074-7613, DOI: 10.1016/j.immuni.2005.03.009

DOI:   http://dx.doi.org/10.1016/j.immuni.2005.03.009
 [A]   WIMER-MACKIN S ET AL: "Transmembrane Domain Mutations Influence the Cellular Distribution of Lysosomal Membrane Glycoprotein A", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, AMSTERDAM, NL, vol. 229, no. 2, 13 December 1996 (1996-12-13), pages 472 - 478, XP027275735, ISSN: 0006-291X, [retrieved on 19961213], DOI: 10.1006/BBRC.1996.1828

DOI:   http://dx.doi.org/10.1006/bbrc.1996.1828
by applicantUS5633234
 US8318173
 WO9824893
 WO9200104
 WO9634096
 WO9633735
 EP0598877
 US5413923
 US5625126
 US5633425
 US5569825
 US5661016
 US545806
 US5814318
 US5885793
 US5916771
 US5939598
 US4816567
 EP0171496
 EP0173494
 WO8601533
 WO8702671
 WO9317715
 WO9208802
 WO9100360
 WO9205793
 US4474893
 US4714681
 US4925648
 US5573920
 US5601819
 US4593002
 US4235871
 US4501728
 US4837028
 US4737323
 EP0901463
 WO9837916
 WO9524221
 WO9602655
 US5595897
 FR2719316
 US5744166
 US6207195
 US6025337
 US5972707
 EP0974668
 EP00440267
 WO9428152
 US928944
 WO9617070
 EP0919627
 WO9704119
 WO9627677
 WO9800524
 WO9826048
 WO0050573
 WO9309221
 WO9528494
 WO9501447
 US5747323
 WO9735996
 EP0083286
 EP0206920
 US4769330
 US4772848
 US603112
 US5100587
 US5179993
 WO9440958
 WO9853853
 EP0890362
 US4448765
 US5676954
 US6875748
 US5661133
 US6511832
 WO8605807
 WO8901036
 US5122464
 US5876969
 EP0413622
 US5766883
 EP0394827
 WO9622024
 WO9904813
 US4446128
 US4454116
 US4681762
 US4592002
 US4920209
   BONINI ET AL., J. IMMUNOL., vol. 166, 2001, pages 5250 - 5257
   FERNANDES ET AL., EUR. J. IMMUNOL., vol. 30, no. 8, 2000, pages 2333 - 43
   GODINHO ET AL., PLOS ONE, vol. 9, no. 6, pages e99887
   DE DUVE, EUR. J. BIOCHEM., vol. 137, no. 391, pages 1983
   BLOTTGRIFFITHS, NATURE REVIEWS, MOLECULAR CELL BIOLOGY, 2002
   DELL'ANGELICA ET AL., THE FASEB JOURNAL, vol. 14, 2000, pages 1265 - 1278
   KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 9568 - 9572
   KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5877
   ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403
   ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389
   MYERSMILLER, CABIOS, vol. 4, 1988, pages 11 - 17
   NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 444 - 453
   FEIGNER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 7413 - 7417
   BATZER ET AL., NUCLEIC ACID RES., vol. 19, 1991, pages 5081
   OHTSUKA ET AL., J. BIOL. CHEM., vol. 260, 1985, pages 2605 - 2608
   ROSSOLINI ET AL., MOL. CELL. PROBES, vol. 8, 1994, pages 91 - 98
   JULIANO, BIOCHEM. BIOPHYS. RES. COMMUN., vol. 63, 1975, pages 651
   CARTER, NATURE REV. IMMUNOL., vol. 6, 2006, pages 243
   LONBERGHUSZAR, INT. REV. IMMUNOL., vol. 13, 1995, pages 65 - 93
   MORRISON, SCIENCE, vol. 229, 1985, pages 1202
   OI ET AL., BIOTECHNIQUES, vol. 4, 1986, pages 214
   BOULIANNE ET AL., NATURE, vol. 312, 1984, pages 643
   NEUBERGER ET AL., NATURE, vol. 314, 1985, pages 268
   TUTT ET AL., J. IMMUNOL., vol. 147, 1991, pages 60 - 69
   KOSTELNY, J. IMMUNOL., vol. 148, 1992, pages 1547 - 1553
   PANICALI ET AL., PROC. NAT'L. ACAD. SCI, USA, vol. 79, 1982, pages 4927
   HALBERT ET AL., J. VIROL., vol. 56, 1985, pages 250 - 257
   NAMBAIR ET AL., SCIENCE, vol. 223, 1984, pages 1299
   LANGFORD ET AL., MOLEC. CELL. BIOL., vol. 6, 1986, pages 3191
   CHEN ET AL., J. BIOL. CHEM., vol. 263, no. 18, 1988, pages 8754 - 8
   ARTERBURN ET AL., J. BIOL. CHEM., vol. 265, 1990, pages 7419
   WILLIAMS ET AL., J. CELL BIOL., vol. 111, no. 955, pages 1990
   EDGE, NATURE, vol. 292, 1981, pages 756
   JAY ET AL., J. BIOL. CHEM., vol. 259, 1984, pages 6311
   GOODING ET AL., CRITICAL REVIEW OF IMMUNOLOGY, vol. 10, 1990, pages 53 - 71
   ALVING, IMMUNOL. REV., vol. 145, 1995, pages 197 - 210
   SZOKA, ANN. REV. BIOPHYS. BIOENG., vol. 9, 1980, pages 467
   AHL, BIOCHIM. BIOPHYS. ACTA, vol. 1329, 1997, pages 370 - 382
   YEH ET AL., J. VIROL., vol. 37-39, 1996, pages 559 - 565
   ROUX ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 9079 - 9083
   FELGNER ET AL., METHODS, vol. 5, pages 67 - 75
   GAOHUANG, BBRC, vol. 179, 1991, pages 280 - 285
   MCLACHLAN ET AL., GENE THERAPY, vol. 2, 1995, pages 674 - 622
   HAENSLERSZOKA, BIOCONJUGATE CHEM., vol. 4, 1993, pages 372 - 379
   LOPATA ET AL., NUCLEIC ACID RES., vol. 12, 1984, pages 5707 - 5717
   SMITH ET AL., ANN. REV. MICROBIOL., vol. 49, 1995, pages 807 - 838
   WOLDGOODING, VIROLOGY, vol. 184, 1991, pages 1 - 8
   HEISEKIM, J. CLIN. INVEST., vol. 105, 2000, pages 847 - 85 1
   ENSINGER ET AL., J. VIROL., vol. 10, 1972, pages 328 - 339
   CHRIST ET AL., HUMAN GENE THER., vol. 11, 2000, pages 415 - 427
   LUSKY ET AL., J. VIROL., vol. 73, 1999, pages 8308 - 8319
   YEH ET AL., FASEB JOURNAL, vol. 11, 1997, pages 615 623
   LUSKY ET AL., J. VIROL, vol. 72, 1998, pages 2022 - 2032
   LUSKY ET AL., J. VIROL., vol. 72, 1998, pages 1394 1402 - 203
   GRAHAM ET AL., J. GEN. VIROL., vol. 36, 1977, pages 59 - 72
   FALLAUX ET AL., HUMAN GENE THERAPY, vol. 9, 1998, pages 1909 - 1917
   KROUGHAKGRAHAM, HUMAN GENE THER., vol. 6, 1995, pages 1575 - 1586
   WANG ET AL., GENE THER., vol. 2, 1995, pages 775 - 783
   DEFER ET AL., J. VIROL., vol. 64, 1990, pages 3661 - 3673
   WICKARN ET AL., J. VIROL., vol. 71, 1997, pages 8221 - 8229
   ARRIBERG ET AL., VIROL. CHEM, vol. 268, 1997, pages 6866 - 6869
   MILLERVILE, FASEB J., vol. 9, 1995, pages 190 - 199
   GILBOA ET AL., ADV. EXP. MED. BIOL., vol. 241, 1988, pages 29
   MILLERROSMAN, BIOTECHNIQUES, vol. 7, 1989, pages 980
   DANOSMULLIGAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 6460
   MARKOWITZ ET AL., VIROL, vol. 167, 1988, pages 400
   GOEBEL ET AL., VIROL., vol. 1, 1990, pages 247 - 266
   JOHNSON ET AL., VIROL., vol. 196, 1993, pages 381 - 401
   ANTOINE ET AL., VIROL., vol. 244, 1998, pages 365 - 396
   MAYR ET AL., INFECTION, vol. 3, 1975, pages 6 - 14
   SZYBALSKASZYBALSKI, PROC. NATL. ACAD. SCI. USA, vol. 48, 1992, pages 10847 - 10851
   PICCINI ET AL., METHODS OF ENZYMOLOGY, vol. 153, 1987, pages 545 - 563
   MACKETT ET AL., PROC. NAT'L. ACAD. SCI. USA, vol. 79, 1982, pages 7415
   MACKETT ET AL., J. VIROL, vol. 49, 1982, pages 857
   CHAKRABARTI ET AL., MOL. CELL. BIOL., vol. 5, 1985, pages 3403
   SMITH ET AL., GENE, vol. 25, no. 21, 1983
   MOSS ET AL., J. VIROL., vol. 40, 1981, pages 387
   LJUNGBERG, K.: "Self-replicating alphavirus RNA vaccines", EXPERT REV VACCINES, no. 2, 2015, pages 177 - 94, XP008175780, DOI: 10.1586/14760584.2015.965690

DOI:   http://dx.doi.org/10.1586/14760584.2015.965690
   LUNDSTROM, K.: "Oncolytic Alphaviruses in Cancer Immunotherapy", VACCINES, vol. 5, 2017, pages 9
   LUNDSTROM, K.: "Replicon RNA Viral Vectors as Vaccines", VACCINES, vol. 4, 2016, pages 39
   CAPECHI ET AL., CELL, vol. 22, no. 8, 1980, pages 479 - 488
   CHENOKAYAMA, MOL. CELL BIOL., vol. 7, 1987, pages 2745 2752
   CHU ET AL., NUCLEIC ACID RES., vol. 15, 1987, pages 1311 - 1326
   CURIEL ET AL., AM. I. RESPIR. CELL. MOL. BIOL., vol. 6, 1992, pages 247 - 252
   BENDER ET AL., J. IMMUNOL. METHODS, vol. 196, 1996, pages 121 - 135
   ROMANI ET AL., J. EXP. MED., vol. 169, 1989, pages 1169
   STEINMAN, ANNU. REV. IMMUNOL., vol. 9, 1991, pages 271
   FREUDENTHAL ET AL., PNAS, vol. 87, 1990, pages 7698 - 7702
   MEHTA-DAMANI ET AL., J. IMMUNOL., vol. 153, 1994, pages 996 - 1003
   THOMAS ET AL., J. IMMUNOL., vol. 151, 1993, pages 6840 - 52
   ARTHUR ET AL., CANCER GENE THERAPY, vol. 4, no. 1, 1997, pages 17 - 25
   ZEMMOURPARHAM, IMMUNOGENETICS, vol. 33, 1991, pages 310 - 320
   DARLING: "Current Protocols in Human Genetics", 1994, JOHN WILEY & SONS
   BITTNER ET AL., METHODS IN ENZYMOL., vol. 153, 1987, pages 51 - 544
   FOUNTOULAKIS ET AL., J. BIOCHEM., vol. 270, 1995, pages 3958 - 3964
   HARTIKKA, J. ET AL., HUM. GENE THER., vol. 7, 1996, pages 1205 - 1217
   JOURNAL OF AMERICAN CHEMICAL SOCIETY, vol. 85, 1968, pages 2149 - 2154
   CHOW ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 910 - 914
   BITTLE ET AL., J. GEN. VIROL., vol. 66, 1985, pages 2347 - 2354
   SAHIN ET AL., NAT REV DRUG DISCOV, vol. 13, no. 10, October 2014 (2014-10-01), pages 759 - 80
   KARIKO ET AL., MOL THER, vol. 16, no. 11, November 2008 (2008-11-01), pages 1833 - 40
   KARIKO ET AL., NUCLEIC ACID RES, vol. 39, no. 21, November 2011 (2011-11-01), pages e142
   FOECKING ET AL., GENE, vol. 45, 1986, pages 101
   COCKETT ET AL., BIO/TECHNOLOGY, vol. 8, 1990, pages 2
   RUTHER ET AL., EMBO, vol. 1, no. 2, 1983, pages 1791
   INOUYEINOUYE, NUCLEIC ACIDS RES., vol. 13, 1985, pages 3101 - 3109
   VAN HEEKESCHUSTER, J. BIOL. CHEM., vol. 24, 1989, pages 5503 - 5509
   LOGANSHENK, PROC. NATL. ACAD. SCI. USA, vol. 8, no. 1, 1984, pages 355 - 359
   WIGLER ET AL., CELL, vol. 11, 1977, pages 223
   WIGLER ET AL., NATL. ACAD. SCI. USA, vol. 77, 1980, pages 357
   O'HARE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 78, 1981, pages 2072
   GOLDSPIEL ET AL., CLINICAL PHARMACY, vol. 12, 1993, pages 488 - 505
   WUWU, BIOTHERAPY, vol. 3, 1991, pages 87 - 95
   TOLSTOSHEV, ANN. REV. PHARMACOL. TOXICOL., vol. 32, 1993, pages 573 - 596
   MULLIGAN, SCIENCE, vol. 260, 1993, pages 926 - 932
   MORGANANDERSON, ANN. REV. BIOCHEM., vol. 62, 1993, pages 191 - 217
   TIB TECH, vol. 11, no. 5, May 1993 (1993-05-01), pages 155 - 2 15
   SANTERRE ET AL., GENE, vol. 30, 1984, pages 147
   "Current Protocols in Molecular Biology", 1993, JOHN WILEY & SONS
   KRIEGLER: "Gene Transfer and Expression, A Laboratory Manual", 1990, STOCKTON PRESS
   COLBERRE-GARAPIN ET AL., J. MOL. BIOL., vol. 150, 1981, pages 1
   BEBBINGTONHENTSCHEL: "The Use Of Vectors Based On Gene Amplification For The Expression Of Cloned Genes In Mammalian Cells In DNA Cloning", vol. 3, 1987, ACADEMIC PRESS
   CROUSE ET AL., MOL. CELL. BIOL., vol. 3, 1983, pages 257
   PROUDFOOT, NATURE, vol. 322, 1986, pages 52
   KOHLER, PROC. NATL. ACAD. SCI. USA, vol. 77, no. 2, 1980, pages 197
   TRAUNECKER ET AL., NATURE, vol. 331, 1988, pages 84 - 86
   JANKNECHT ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 8972 - 897
   KAMI KDOI RKOIZUMI MTOYODA EMORI TITO D ET AL.: "Survivin expression is a prognostic marker in pancreatic cancer patients", SURGERY, vol. 136, no. 2, 2004, pages 443 - 8, XP087248471, DOI: 10.1016/j.surg.2004.05.023

DOI:   http://dx.doi.org/10.1016/j.surg.2004.05.023
   ZHANG SQQIANG SYYANG WBJIANG JTJI ZZ: "Expression of survivin in different stages of carcinogenesis and progression of breast cancer", AI ZHENG., vol. 23, no. 6, 2004, pages 697 - 700
   ZHANG XZHONG LHU KLI Q: "Expression of survivin and its correlation with apoptosis in non-small cell lung cancer", ZHONGGUO FEI AI ZA ZHI., vol. 7, no. 2, 2004, pages 138 - 41
   KISHI HIGAWA MKIKUNO NYOSHINO TURAKAMI SSHIINA H: "Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis", J UROL., vol. 171, no. 5, 2004, pages 1855 - 60, XP005533167, DOI: 10.1097/01.ju.0000120317.88372.03

DOI:   http://dx.doi.org/10.1097/01.ju.0000120317.88372.03
   ASANUMA KTSUJI NENDOH TYAGIHASHI AWATANABE N: "Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells", J IMMUNOL., vol. 172, no. 6, 2004, pages 3922 - 9
   MIYACHI KSASAKI KONODERA STAGUCHI TNAGAMACHI MKANEKO H ET AL.: "Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer", GASTRIC CANCER., vol. 6, no. 4, 2003, pages 217 - 24
   BADANA AKCHINTALA MGAVARA MMNAIK SKUMARI SKAPPALA VR ET AL.: "Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer", BIOMED PHARMACOTHER., vol. 97, 2017, pages 359 - 68, XP085323753, DOI: 10.1016/j.biopha.2017.10.045

DOI:   http://dx.doi.org/10.1016/j.biopha.2017.10.045
   CAI JPWANG YDZHANG XXUE HZ: "Expression of P16 and survivin in liver cancer and their clinical significance", ZHONGHUA GAN ZANG BING ZA ZHI., vol. 25, no. 10, 2017, pages 778 - 80
   CHO HJKIM HRPARK YSKIM YHKIM DKPARK SI: "Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy", SURG ONCOL., vol. 24, no. 4, 2015, pages 329 - 34, XP029358339, DOI: 10.1016/j.suronc.2015.09.001

DOI:   http://dx.doi.org/10.1016/j.suronc.2015.09.001
   GODINHO RMMATASSOLI FLLUCAS CGRIGATO POGONCALVES JLSATO MN ET AL.: "Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP- ) enhance Gag-specific immune response", PLOS ONE., vol. 9, no. 6, 2014, pages e99887, XP055484045, DOI: 10.1371/journal.pone.0099887

DOI:   http://dx.doi.org/10.1371/journal.pone.0099887
   SU ET AL., J OF IMMUNOL RES, no. 10, 2016, pages 1 - 15
   KOHLER ET AL., NATURE, vol. 256, 1975, pages 495
   KOHLER ET AL., EUR. J. IMMUNOL., vol. 6, 1976, pages 292
   WANDS ET AL., GASTROENTEROLOGY, vol. 80, 1981, pages 225 - 232
   "Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council", NATIONAL ACADEMY PRESS, article "Guide for the Use and Care of Laboratory Animals"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.